Neutral
Last updated: 2026-06-14 02:57:35 ET
Regulator approval means patients who meet criteria will be able to purchase tablets with private prescription Patients in the UK will soon be able to...
Nutrition companies are struggling to keep up as the wellness craze and GLP-1 boom drive up demand for a once-niche supplement.
Customers have complained that a telehealth network selling compounded GLP-1s has been ripping them off—even after it had to pay $5 million to clien...
Research suggests households that include a GLP-1 user collectively spent £780m less on grocery billsBusiness live – latest updatesWeight-loss drug...
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE